Related by context. Frequent words. (Click for all words.) 62 JZP 6 53 Zelrix 51 alvimopan 50 Exalgo 50 Vimovo 49 Icatibant 49 Krystexxa 48 Promacta 48 SILENOR TM 48 OFIRMEV 48 sBLA 48 AVINZA 47 Onsolis 47 mg dosage 47 alogliptin 47 Replagal 46 PREOS 46 Phenoptin 46 MOZOBIL 46 MYoung Texas 45 methylnaltrexone 45 KRYSTEXXA 45 Orphan Drug Status 45 Orphan Drug designation 45 BRoberts Baltimore 45 Marketing Authorization Application 45 PDUFA date 45 talactoferrin 45 Freel Cincinnati 44 Relistor 44 Allovectin 7 R 44 Marketing Authorization Application MAA 44 supplemental Biologics License Application 44 BEMA Fentanyl 44 ATryn ® 44 InKine 44 VWells Toronto 44 Rhucin ® 43 GEM #S 43 prGCD 43 Phase IIa clinical trials 43 orphan designation 43 regulatory approval 43 Recothrom 43 Orphan Drug status 43 confirmatory Phase III 43 BLA submission 43 Vasovist 43 Flutiform 43 Noncritical violations found 43 European Medicines Evaluation 42 HaRamirez Florida 42 BENLYSTA 42 Neuromed 42 Cypress Bioscience 42 Clolar 42 Gestiva 42 Zerenex 42 Investigational Device Exemption 42 ELAPRASE 42 vernakalant iv 42 Fast Track Designation 42 ambrisentan 42 Biologics License Application BLA 41 Paladin Labs 41 New Drug Application 41 Eligard 41 Rhucin 41 Approvable Letter 41 Drug Application 41 FIRAZYR 41 Renvela 41 MiCabrera Florida 41 biogeneric 41 approvable letter 41 Opana ER 41 orphan drug 41 Mozobil 41 pralatrexate 41 MRamirez Boston 41 pediatric exclusivity 41 Marketing Authorization 40 commercialization milestones 40 ASoriano Texas 40 AHill Toronto 40 stockholder approvals 40 MONOVISC 40 Cannasat 40 Esbriet 40 Biologics License Application 40 voclosporin 40 BYDUREON 40 Phase III clinical trials 40 FDA Approval 40 clinical trials 40 Orphan Drug Designation 40 ATryn R 40 ADVENTRX Pharmaceuticals 40 NDA submission 40 g trans fats 40 Priority Review